aTyr Pharma, Inc. (ATYR)
USD 3.15
(2.27%)
USD 3.15
(2.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -33.22 Million | -41.88 Million | -33.07 Million | -15.3 Million | -20.01 Million | -31.06 Million |
| Net Income | -50.38 Million | -45.33 Million | -33.76 Million | -16.22 Million | -23.6 Million | -34.51 Million |
| Depreciation & Amortization | 2.74 Million | 1.69 Million | 1.3 Million | 1.26 Million | 1.36 Million | 746 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.6 Million | 2.15 Million | 1.61 Million | 1.46 Million | 1.78 Million | - |
| Change in working capital | 15.01 Million | -833 Thousand | -2.58 Million | -2.26 Million | 206 Thousand | -1.44 Million |
| Other non-cash items | -7.41 Million | 11.16 Million | 2.93 Million | 4.62 Million | 4.58 Million | 7.7 Million |
| Investing Cash Flow | -20.12 Million | 47.24 Million | -91.56 Million | 6.9 Million | 4.92 Million | 37.17 Million |
| Investments in PPE | -4.21 Million | -1.64 Million | -192 Thousand | -202 Thousand | -79 Thousand | -594 Thousand |
| Acquisitions | 15 Thousand | 179 Thousand | 50 Thousand | 18 Thousand | 51 Thousand | - |
| Investment purchases | -106.97 Million | -42.11 Million | -126.5 Million | -21.06 Million | -40.64 Million | -40.29 Million |
| Sales/Maturities of investments | 91.05 Million | 90.82 Million | 35.08 Million | 28.15 Million | 45.6 Million | 78.06 Million |
| Other Investing Activities | -15.91 Million | 48.88 Million | -91.37 Million | 7.1 Million | 5 Million | - |
| Financing Cash Flow | 66.23 Million | 5.45 Million | 110.02 Million | 16.14 Million | 1.33 Million | -4.23 Million |
| Debt repayment | -394 Thousand | -66 Thousand | - | -9.69 Million | -8 Million | -4.66 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 66.62 Million | 5.51 Million | 110.02 Million | 6.44 Million | 9.33 Million | 429 Thousand |
| Other Financing Activities | 66.62 Million | 5.51 Million | 110.02 Million | 25.22 Million | 9.33 Million | - |
| Accounts receivables | 9.05 Million | -11.92 Million | 1.6 Million | -1.93 Million | 58 Thousand | - |
| Accounts payables | 3.26 Million | 6.74 Million | 47 Thousand | 1.76 Million | 162 Thousand | -2.05 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.69 Million | 4.34 Million | -4.23 Million | -2.08 Million | 44 Thousand | 610 Thousand |
| Cash at beginning of period | 9.98 Million | 2.33 Million | 16.95 Million | 9.21 Million | 22.96 Million | 21.09 Million |
| Cash at end of period | 22.54 Million | 9.98 Million | 2.33 Million | 16.95 Million | 9.21 Million | 22.96 Million |
| Capital Expenditure | -4.21 Million | -1.64 Million | -192 Thousand | -202 Thousand | -79 Thousand | -594 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 12.56 Million | 7.64 Million | -14.61 Million | 7.74 Million | -13.75 Million | 1.87 Million |
| Free Cash Flow | -37.43 Million | -43.52 Million | -33.26 Million | -15.5 Million | -20.09 Million | -31.65 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.3 Million | -15.49 Million | -14.76 Million | -50.38 Million | -11.34 Million | -12.33 Million |
| Depreciation & Amortization | 383 Thousand | 770 Thousand | 407 Thousand | 2.74 Million | 993 Thousand | 586 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 727 Thousand | 740 Thousand | 659 Thousand | 2.6 Million | 664 Thousand | 658 Thousand |
| Change in working capital | -4.51 Million | -7.59 Million | 3.51 Million | 15.01 Million | 1.1 Million | -17 Thousand |
| Other non-cash items | 4.88 Million | 1.24 Million | -2.34 Million | -7.41 Million | 1.82 Million | 222 Thousand |
| Investing Cash Flow | 6.72 Million | -1.35 Million | 17.81 Million | -20.12 Million | 4.38 Million | -4.15 Million |
| Investments in PPE | -8000.00 | -17 Thousand | -17 Thousand | -4.21 Million | -557 Thousand | -2.39 Million |
| Acquisitions | - | - | - | 15 Thousand | - | 15 Thousand |
| Investment purchases | -18.78 Million | -21.33 Million | -9.66 Million | -106.97 Million | -28.61 Million | -22.47 Million |
| Sales/Maturities of investments | 25.52 Million | 20 Million | 27.5 Million | 91.05 Million | 33.54 Million | 20.7 Million |
| Other Investing Activities | 6.73 Million | -1.33 Million | 17.83 Million | -15.91 Million | 4.94 Million | -1.76 Million |
| Financing Cash Flow | 13.4 Million | 7.73 Million | 6.03 Million | 66.23 Million | 2.68 Million | 8.01 Million |
| Debt repayment | -123 Thousand | -121 Thousand | -115 Thousand | -394 Thousand | -108 Thousand | -105 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 13.52 Million | 7.85 Million | 6.14 Million | 66.62 Million | 2.79 Million | 8.12 Million |
| Other Financing Activities | 13.52 Million | 7.85 Million | 6.14 Million | 66.62 Million | 2.79 Million | 8.12 Million |
| Accounts receivables | 56 Thousand | 454 Thousand | -458 Thousand | 9.05 Million | -1.04 Million | 671 Thousand |
| Accounts payables | -4.17 Million | -228 Thousand | 3.38 Million | 3.26 Million | 893 Thousand | 38 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -395 Thousand | -7.81 Million | 589 Thousand | 2.69 Million | 1.25 Million | -726 Thousand |
| Cash at beginning of period | 6.8 Million | 22.54 Million | 9.78 Million | 9.98 Million | 12.31 Million | 20.69 Million |
| Cash at end of period | 6.8 Million | 6.8 Million | 22.54 Million | 22.54 Million | 9.78 Million | 12.31 Million |
| Capital Expenditure | -8000.00 | -17 Thousand | -17 Thousand | -4.21 Million | -557 Thousand | -2.39 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3000.00 | -15.73 Million | 12.75 Million | 12.56 Million | -2.52 Million | -8.37 Million |
| Free Cash Flow | -20.45 Million | -22.39 Million | -11.07 Million | -37.43 Million | -10.11 Million | -14.4 Million |
6876
PBI
HL
002795
ARC
015260